Needle-Free Diabetes Care Market - Global Industry Analysis

Needle-Free Diabetes Care Market By Devices Types (Treatment Devices and Diagnostic Devices), By Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, and Others), By Application (Insulin Delivery and Other), By End-User (Diagnostic Centers, Hospitals & Clinics, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 03-Aug-2022 Category: Healthcare Report Format : PDF Pages: 204 Report Code: ZMR-6016 Status : Published

The global needle-free diabetes care market size was worth USD 9.1 billion in 2021 and is estimated to grow to USD 13.4 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.7% over the forecast period.

Description

Industry Perspective:

The global needle-free diabetes care market size was worth USD 9.1 billion in 2021 and is estimated to grow to USD 13.4 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.7% over the forecast period. The report analyzes the needle-free diabetes care market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the needle-free diabetes care market.

Needle - Free Diabetes Care Market: Overview

Diabetes is a collection of metabolic illnesses in which a person's blood sugar levels are elevated due to insufficient insulin production, improper cell response to insulin, or both or neither of these factors. To diagnose a patient, blood samples are typically drawn from them. This technique can result in needle-stick injuries, leading to several infections and suffering. People are using non-invasive, needle-free diabetic products as a result. During the projected period, an expanding patient population with diabetes and a rising prevalence of type 1 diabetes are expected to propel market expansion. Traditionally, patients with type 1 diabetes who need frequent glucose testing use needles, which raises the risk of infection and discomfort for people. The use of needle-free equipment reduces delivery discomfort and infection risk. Therefore, it is anticipated that there will be an increase in demand for these devices during the forecast period. Additionally, the industry has been driven by rising demand and technological developments in pain-free drug transportation and self-administration. However, the high cost of the facility and worries about technical difficulties are the factors anticipated to restrain the market's expansion for needle-free diabetes care.

Global Needle-Free Diabetes Care Market

COVID-19 Impact:

In a best-case scenario, it may be assumed that the COVID-19 epidemic has positively affected the adoption of needle-free injection systems. The COVID-19 pandemic has favorably impacted the global needle-free diabetes care market. It has brought attention to the necessity for self-injectable devices and mass vaccinations since the pandemic outbreak began in December 2019. To develop a needle-free injection system for the disease, as the number of cases has increased across regions, most hand-free injection system players have invested in R&D and have formed partnerships & agreements with other business and governmental entities.

Key Insights

  • As per the analysis shared by our research analyst, the global needle-free diabetes care market value is predicted to grow at a CAGR of 6.7% over the forecast period. 
  • In terms of revenue, the global needle-free diabetes care market size was valued at around USD 9.1 billion in 2021 and is projected to reach USD 13.4 billion by 2028. 
  • One of the key factors propelling the expansion of the needle-free diabetes care market is the development of transdermal patches that measure blood sugar levels through the skin without extracting blood.
  • In 2021, North America was responsible for roughly 58.0% of total revenue.
  • With its high efficiency, the insulin patch market was shown to have the fastest growing market share in 2021.
  • In 2021, insulin administration was the most widely used needle-free drug delivery device.

Needle - Free Diabetes Care Market: Growth Drivers

Increasing diabetes prevalence drives global needle-free diabetes care market growth

Diabetes is anticipated to be the sixth most significant cause of death by 2030, according to the WHO. Stress, sedentary habits, poor diets, and obesity are the main diabetes risk factors. Physiological changes brought on by aging play a sizable role in diabetes risk. For instance, the International Diabetes Federation claims that the prevalence of diabetes rises with age. Therefore, those over 65 years old are thought to have the highest estimated risk of diabetes. Adults aged 20 to 24 had the lowest prevalence of diabetes (2.2% in 2021). Diabetes prevalence is at 24.0% among persons aged 75 to 79 as of 2021 and is expected to rise to 24.7% by 2045. According to these figures, most diabetes will significantly grow over the next 25 years in nations with substantial geriatric populations. Therefore, it is anticipated that the need for needles less diabetes management solutions will be driven by the growing elderly population and the population's increased exposure to leading risk factors.

Needle Free Diabetes Care Market: Restraints

More people using traditional diabetes management tools restraints the market demand

Patients still favor conventional diabetes management strategies in various geographical areas. With their low cost and lack of information about linked devices and apps, many patients reject advanced platforms in favor of traditional blood glucose readers, glucose strips, insulin injections, prefilled syringes, and medication therapy. The limited knowledge for managing diabetes in various nations has also impacted the acceptance of cutting-edge technologies. The use of needle-less diabetes management has been negatively affected in Asia, the Middle East, and Africa due to low awareness, a lack of educated staff, and unfavorable/minimal reimbursements. The market expansion in China and India is also being constrained by the reliance on complementary traditional diabetes control techniques like herbal medications.

Needle-Free Diabetes Care Market: Segmentation

The global needle-free diabetes care market is segregated based on device types, treatment, application, end users, and region.

By treatment, the market is divided into oral insulin, inhaled insulin, insulin patch, and others. With its outstanding efficiency, the insulin patch segment was shown to have the fastest expanding market share in 2021. The significant growth rate can be ascribed to elements like the rising incidence of diabetes and growing public knowledge of sophisticated patch pumps. People with type 1 diabetes prefer insulin patch pumps since they do not need to carry an insulin infusion set. Patch pumps are chosen by older and working individuals because of their greater convenience. Patch pumps are generally smaller, more discrete, and easier to use than conventional insulin pumps. These pumps are also more affordable than traditional insulin delivery methods, which boosts demand. Patch pumps use an adhesive coating to bond to the skin and need minimal supervision. These pumps typically come with a blood glucose monitoring system or a continuous glucose monitor.

Based on application, the market is divided into insulin delivery and others. The global needle-free diabetes care market's most popular application area in 2021 was insulin delivery. The enormous population with diabetes drives the demand for insulin delivery devices. Additionally, the widespread use of recently introduced inventive pen devices and portable pumps is being aided by the rising demand for sophisticated insulin delivery systems, which is anticipated to accelerate market expansion.

Recent Developments

  • In May 2022, Endo International plc announced that its subsidiary Endo Ventures Limited (EVL) had acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiary of Nevakar, Inc.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Needle - Free Diabetes Care Market: Regional Landscape

Growing prevalence of diabetics likely to help North America dominate the global market

North America held a monopoly on the global needle-free diabetes care market in 2021. The significant market growth in North America is mainly due to the increased number of diabetics and the availability of technologically improved equipment. By 2025, there are likely to be 5 million Canadians living with diabetes, according to the Canadian Diabetes Association. Therefore, it is anticipated that the vast patient population suffering from diabetes and its rising prevalence will spur growth in this area. The region's dominance in the international arena has been aided by a high level of awareness regarding the potential advantages of needle-free drug delivery devices. Additionally, the market is expanding due to the availability of highly developed healthcare facilities and significant R&D spending by government agencies and pharmaceutical corporations to treat diabetes.

Needle - Free Diabetes Care Market: Competitive Landscape 

Some of the main competitors dominating the global needle-free diabetes care market include - European Pharma Group, Medical International Technology Inc., Antares Pharma Inc., Zogenix Inc., 3M Company, Valeritas Inc., Endo International plc., INJEX Pharma AG, and Bioject Medical Technologies Inc.

The global Needle-Free Diabetes Care Market is segmented as follows:

By Devices Types

  • Treatment Devices
  • Diagnostic Devices

By Treatment

  • Oral Insulin
  • Inhaled Insulin
  • Insulin Patch
  • Others

By Application

  • Insulin Delivery
  • Other

By End Users

  • Diagnostic Centers
  • Hospitals & Clinics And Other

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of  the Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Needle-Free Diabetes Care Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Needle-Free Diabetes Care Market : snapshot
  • Chapter 3. Global Needle-Free Diabetes Care Market - Industry Analysis
    • 3.1 Needle-Free Diabetes Care Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing diabetes prevalence drives global needle-free diabetes care market growth
    • 3.3 Market Restraints
      • 3.3.1. More people using traditional diabetes management tools restraints the market demand
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Devices Types
      • 3.7.2 Market attractiveness analysis By Treatment
      • 3.7.3 Market attractiveness analysis By Application
      • 3.7.4 Market attractiveness analysis By End Users
  • Chapter 4. Global Needle-Free Diabetes Care Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Needle-Free Diabetes Care Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Needle-Free Diabetes Care Market - Devices Types Analysis
    • 5.1 Global Needle-Free Diabetes Care Market overview: By Devices Types
      • 5.1.1 Global Needle-Free Diabetes Care Market share, By Devices Types, 2021 and 2028
    • 5.2 Treatment Devices
      • 5.2.1 Global Needle-Free Diabetes Care Market by Treatment Devices, 2022 - 2028 (USD Billion)
    • 5.3 Diagnostic Devices
      • 5.3.1 Global Needle-Free Diabetes Care Market by Diagnostic Devices, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Needle-Free Diabetes Care Market - Treatment Analysis
    • 6.1 Global Needle-Free Diabetes Care Market overview: By Treatment
      • 6.1.1 Global Needle-Free Diabetes Care Market share, By Treatment, 2021 and 2028
    • 6.2 Oral Insulin
      • 6.2.1 Global Needle-Free Diabetes Care Market by Oral Insulin, 2022 - 2028 (USD Billion)
    • 6.3 Inhaled Insulin
      • 6.3.1 Global Needle-Free Diabetes Care Market by Inhaled Insulin, 2022 - 2028 (USD Billion)
    • 6.4 Insulin Patch
      • 6.4.1 Global Needle-Free Diabetes Care Market by Insulin Patch, 2022 - 2028 (USD Billion)
    • 6.5 Others
      • 6.5.1 Global Needle-Free Diabetes Care Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Needle-Free Diabetes Care Market - Application Analysis
    • 7.1 Global Needle-Free Diabetes Care Market overview: By Application
      • 7.1.1 Global Needle-Free Diabetes Care Market share, By Application, 2021 and 2028
    • 7.2 Insulin Delivery
      • 7.2.1 Global Needle-Free Diabetes Care Market by Insulin Delivery, 2022 - 2028 (USD Billion)
    • 7.3 Other
      • 7.3.1 Global Needle-Free Diabetes Care Market by Other, 2022 - 2028 (USD Billion)
  • Chapter 8. Global Needle-Free Diabetes Care Market - End Users Analysis
    • 8.1 Global Needle-Free Diabetes Care Market overview: By End Users
      • 8.1.1 Global Needle-Free Diabetes Care Market share, By End Users, 2021 and 2028
    • 8.2 Diagnostic Centers
      • 8.2.1 Global Needle-Free Diabetes Care Market by Diagnostic Centers, 2022 - 2028 (USD Billion)
    • 8.3 Hospitals & Clinics And Other
      • 8.3.1 Global Needle-Free Diabetes Care Market by Hospitals & Clinics And Other, 2022 - 2028 (USD Billion)
  • Chapter 9. Needle-Free Diabetes Care Market - Regional Analysis
    • 9.1 Global Needle-Free Diabetes Care Market Regional Overview
    • 9.2 Global Needle-Free Diabetes Care Market Share, by Region, 2021 & 2028 (USD Billion)
    • 9.3. North America
      • 9.3.1 North America Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
        • 9.3.1.1 North America Needle-Free Diabetes Care Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 North America Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028
      • 9.4.1 North America Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028 (USD Billion)
    • 9.5 North America Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028
      • 9.5.1 North America Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028 (USD Billion)
    • 9.6 North America Needle-Free Diabetes Care Market, by Application, 2022 - 2028
      • 9.6.1 North America Needle-Free Diabetes Care Market, by Application, 2022 - 2028 (USD Billion)
    • 9.7 North America Needle-Free Diabetes Care Market, by End Users, 2022 - 2028
      • 9.7.1 North America Needle-Free Diabetes Care Market, by End Users, 2022 - 2028 (USD Billion)
    • 9.4. Europe
      • 9.4.2 Europe Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
        • 9.4.2.1 Europe Needle-Free Diabetes Care Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Europe Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028
      • 9.4.1 Europe Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028 (USD Billion)
    • 9.5 Europe Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028
      • 9.5.1 Europe Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028 (USD Billion)
    • 9.6 Europe Needle-Free Diabetes Care Market, by Application, 2022 - 2028
      • 9.6.1 Europe Needle-Free Diabetes Care Market, by Application, 2022 - 2028 (USD Billion)
    • 9.7 Europe Needle-Free Diabetes Care Market, by End Users, 2022 - 2028
      • 9.7.1 Europe Needle-Free Diabetes Care Market, by End Users, 2022 - 2028 (USD Billion)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
        • 9.5.3.1 Asia Pacific Needle-Free Diabetes Care Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Asia Pacific Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028
      • 9.4.1 Asia Pacific Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028 (USD Billion)
    • 9.5 Asia Pacific Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028
      • 9.5.1 Asia Pacific Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028 (USD Billion)
    • 9.6 Asia Pacific Needle-Free Diabetes Care Market, by Application, 2022 - 2028
      • 9.6.1 Asia Pacific Needle-Free Diabetes Care Market, by Application, 2022 - 2028 (USD Billion)
    • 9.7 Asia Pacific Needle-Free Diabetes Care Market, by End Users, 2022 - 2028
      • 9.7.1 Asia Pacific Needle-Free Diabetes Care Market, by End Users, 2022 - 2028 (USD Billion)
    • 9.6. Latin America
      • 9.6.4 Latin America Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
        • 9.6.4.1 Latin America Needle-Free Diabetes Care Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Latin America Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028
      • 9.4.1 Latin America Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028 (USD Billion)
    • 9.5 Latin America Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028
      • 9.5.1 Latin America Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028 (USD Billion)
    • 9.6 Latin America Needle-Free Diabetes Care Market, by Application, 2022 - 2028
      • 9.6.1 Latin America Needle-Free Diabetes Care Market, by Application, 2022 - 2028 (USD Billion)
    • 9.7 Latin America Needle-Free Diabetes Care Market, by End Users, 2022 - 2028
      • 9.7.1 Latin America Needle-Free Diabetes Care Market, by End Users, 2022 - 2028 (USD Billion)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
        • 9.7.5.1 The Middle-East and Africa Needle-Free Diabetes Care Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 The Middle-East and Africa Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028
      • 9.4.1 The Middle-East and Africa Needle-Free Diabetes Care Market, by Devices Types, 2022 - 2028 (USD Billion)
    • 9.5 The Middle-East and Africa Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028
      • 9.5.1 The Middle-East and Africa Needle-Free Diabetes Care Market, by Treatment, 2022 - 2028 (USD Billion)
    • 9.6 The Middle-East and Africa Needle-Free Diabetes Care Market, by Application, 2022 - 2028
      • 9.6.1 The Middle-East and Africa Needle-Free Diabetes Care Market, by Application, 2022 - 2028 (USD Billion)
    • 9.7 The Middle-East and Africa Needle-Free Diabetes Care Market, by End Users, 2022 - 2028
      • 9.7.1 The Middle-East and Africa Needle-Free Diabetes Care Market, by End Users, 2022 - 2028 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1 European Pharma Group
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Medical International Technology Inc.
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Antares Pharma Inc.
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Zogenix Inc.
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 3M Company
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Valeritas Inc.
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 Endo International plc.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 INJEX Pharma AG
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Bioject Medical Technologies Inc.
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Needle-Free Diabetes Care Market attractiveness, By Devices Types
  • 6. Global Needle-Free Diabetes Care Market attractiveness, By Treatment
  • 7. Global Needle-Free Diabetes Care Market attractiveness, By Application
  • 8. Global Needle-Free Diabetes Care Market attractiveness, By End Users
  • 9. Global Needle-Free Diabetes Care Market share by Devices Types, 2022 and 2028 (USD Billion)
  • 10. Global Needle-Free Diabetes Care Market by Treatment Devices, 2022 - 2028 (USD Billion)
  • 11. Global Needle-Free Diabetes Care Market by Diagnostic Devices, 2022 - 2028 (USD Billion)
  • 12. Global Needle-Free Diabetes Care Market share by Treatment, 2022 and 2028 (USD Billion)
  • 13. Global Needle-Free Diabetes Care Market by Oral Insulin, 2022 - 2028 (USD Billion)
  • 14. Global Needle-Free Diabetes Care Market by Inhaled Insulin, 2022 - 2028 (USD Billion)
  • 15. Global Needle-Free Diabetes Care Market by Insulin Patch, 2022 - 2028 (USD Billion)
  • 16. Global Needle-Free Diabetes Care Market by Others, 2022 - 2028 (USD Billion)
  • 17. Global Needle-Free Diabetes Care Market share by Application, 2022 and 2028 (USD Billion)
  • 18. Global Needle-Free Diabetes Care Market by Insulin Delivery, 2022 - 2028 (USD Billion)
  • 19. Global Needle-Free Diabetes Care Market by Other, 2022 - 2028 (USD Billion)
  • 20. Global Needle-Free Diabetes Care Market share by End Users, 2022 and 2028 (USD Billion)
  • 21. Global Needle-Free Diabetes Care Market by Diagnostic Centers, 2022 - 2028 (USD Billion)
  • 22. Global Needle-Free Diabetes Care Market by Hospitals & Clinics And Other, 2022 - 2028 (USD Billion)
  • 23. Global Needle-Free Diabetes Care Market share, by Region, 2022 and 2028
  • 24. North America Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
  • 25. Europe Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
  • 26. Asia Pacific Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
  • 27. Latin America Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)
  • 28. The Middle-East and Africa Needle-Free Diabetes Care Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Needle-Free Diabetes Care Market: Snapshot
  • 2. Drivers of the Needle-Free Diabetes Care Market: impact analysis
  • 3. North America Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 4. North America Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 5. North America Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 6. North America Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 7. U.S. Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 8. U.S. Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 9. U.S. Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 10. U.S. Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 11. Canada Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 12. Canada Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 13. Canada Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 14. Canada Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 15. Europe Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 16. Europe Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 17. Europe Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 18. Europe Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 19. Germany Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 20. Germany Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 21. Germany Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 22. Germany Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 23. France Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 24. France Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 25. France Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 26. France Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 27. U.K. Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 28. U.K. Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 29. U.K. Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 30. U.K. Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 31. Italy Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 32. Italy Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 33. Italy Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 34. Italy Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 35. Spain Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 36. Spain Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 37. Spain Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 38. Spain Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 39. Rest of Europe Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 40. Rest of Europe Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 41. Rest of Europe Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 42. Rest of Europe Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 43. Asia Pacific Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 44. Asia Pacific Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 45. Asia Pacific Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 46. Asia Pacific Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 47. China Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 48. China Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 49. China Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 50. China Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 51. Japan Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 52. Japan Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 53. Japan Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 54. Japan Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 55. India Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 56. India Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 57. India Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 58. India Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 59. South Korea Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 60. South Korea Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 61. South Korea Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 62. South Korea Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 63. South-East Asia Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 64. South-East Asia Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 65. South-East Asia Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 66. South-East Asia Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 67. Rest of Asia Pacific Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 68. Rest of Asia Pacific Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 69. Rest of Asia Pacific Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 70. Rest of Asia Pacific Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 71. Latin America Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 72. Latin America Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 73. Latin America Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 74. Latin America Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 75. Brazil Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 76. Brazil Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 77. Brazil Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 78. Brazil Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 79. Mexico Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 80. Mexico Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 81. Mexico Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 82. Mexico Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 83. Rest of Latin America Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 84. Rest of Latin America Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 85. Rest of Latin America Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 86. Rest of Latin America Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 87. The Middle-East and Africa Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 88. The Middle-East and Africa Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 89. The Middle-East and Africa Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 90. The Middle-East and Africa Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 91. GCC Countries Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 92. GCC Countries Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 93. GCC Countries Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 94. GCC Countries Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 95. South Africa Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 96. South Africa Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 97. South Africa Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 98. South Africa Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)
  • 99. Rest of Middle-East Africa Needle-Free Diabetes Care Market revenue, By Devices Types, 2022 - 2028 (USD Billion)
  • 100. Rest of Middle-East Africa Needle-Free Diabetes Care Market revenue, By Treatment, 2022 - 2028 (USD Billion)
  • 101. Rest of Middle-East Africa Needle-Free Diabetes Care Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 102. Rest of Middle-East Africa Needle-Free Diabetes Care Market revenue, By End Users, 2022 - 2028 (USD Billion)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

One of the key drivers fueling the expansion of the needle-free diabetes treatment market is the development of transdermal patches, which measure blood sugar levels via the skin without extracting blood.

According to the report, the global needle-free diabetes care market was worth about 9.1 (USD billion) in 2021 and is predicted to grow to around 13.4 (USD billion) by 2028, along with a compound annual growth rate (CAGR) of approximately 6.7%.

North America now monopolizes the needle-free diabetes treatment industry due to its vast diabetic population, changing lifestyle, rising healthcare costs, and adaptive population.

Some of the main competitors dominating the global needle-free diabetes care market include - European Pharma Group, Medical International Technology Inc., Antares Pharma Inc., Zogenix Inc., 3M Company, Valeritas Inc., Endo International plc., INJEX Pharma AG, and Bioject Medical Technologies Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed